Our current analysis of TCGA data and PANCAN_RPPA data and from breast cancer patients show that elevated expression of Kaiso is associated with increased CD47 and SIRPA and decreased THPS1 in ER-negative basal-like tumors. Here, CD47 is linked to breast carcinoma.